We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
-13.16%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+535.77%
AUM
$3.2B
AUM Growth
-$730M
Cap. Flow
-$164M
Cap. Flow %
-5.14%
Top 10 Hldgs %
14.44%
Holding
1,433
New
85
Increased
447
Reduced
621
Closed
196

Top Buys

Rank Stock Value
1
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$7.65M
2
VZ icon
Verizon
VZ
+$4.92M
3
LIN icon
Linde
LIN
+$4.78M
4
ILMN icon
Illumina
ILMN
+$4.5M
5
AAPL icon
Apple
AAPL
+$4.21M

Sector Composition

Rank Sector Weight
1 Healthcare 13.46%
2 Technology 12.76%
3 Financials 11.37%
4 Industrials 8.31%
5 Consumer Discretionary 7.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDR
1176
DELISTED
McDermott International
MDR
$114K ﹤0.01%
17,354
-39,226
-69% -$414K
TTMI icon
1177
TTM Technologies
TTMI
$14.1B
$112K ﹤0.01%
11,500
-14,500
-56% -$178K
DNP icon
1178
DNP Select Income Fund
DNP
$4.08B
$111K ﹤0.01%
+10,710
New +$117K
RFI
1179
Cohen & Steers Total Return Realty Fund
RFI
$308M
$111K ﹤0.01%
+10,328
New +$121K
ONDK
1180
DELISTED
On Deck Capital, Inc.
ONDK
$109K ﹤0.01%
+18,557
New +$132K
DSU icon
1181
BlackRock Debt Strategies Fund
DSU
$597M
$108K ﹤0.01%
11,045
HLX icon
1182
Helix Energy Solutions
HLX
$1.45B
$108K ﹤0.01%
20,000
HIE
1183
DELISTED
Miller/Howard High Income Equity Fund
HIE
$107K ﹤0.01%
11,250
+750
+7% +$8.46K
SBBP
1184
DELISTED
Strongbridge Biopharma plc.
SBBP
$107K ﹤0.01%
23,822
-83
-0.3% -$405
DB icon
1185
Deutsche Bank
DB
$72.1B
$102K ﹤0.01%
12,600
-81,480
-87% -$796K
JPC icon
1186
Nuveen Preferred & Income Opportunities Fund
JPC
$2.92B
$100K ﹤0.01%
11,953
-4,938
-29% -$43.6K
SAN icon
1187
Banco Santander
SAN
$211B
$100K ﹤0.01%
23,397
+187
+0.8% +$848
ACCO icon
1188
Acco Brands
ACCO
$399M
$91K ﹤0.01%
13,468
+2,032
+18% +$17.4K
FIV
1189
DELISTED
First Trust Senior Floating Rate 2022 Target Term Fund Common Shares of Beneficial Interest
FIV
$91K ﹤0.01%
11,000
-6,500
-37% -$57.8K
SNDX icon
1190
Syndax Pharmaceuticals
SNDX
$1.82B
$88K ﹤0.01%
19,809
+221
+1% +$1.21K
GSM icon
1191
FerroAtlántica
GSM
$871M
$85K ﹤0.01%
53,530
-116,534
-69% -$558K
NBR icon
1192
Nabors Industries
NBR
$1.3B
$84K ﹤0.01%
839
-70
-8% -$15.4K
MIE
1193
DELISTED
COHEN & STEERS MLP INCOME AND ENERGY OPPORTUNITY FUND, INC.
MIE
$84K ﹤0.01%
11,078
-2,022
-15% -$18.5K
ACH
1194
Accendra Health
ACH
$98M
$82K ﹤0.01%
13,000
-16,000
-55% -$166K
AG icon
1195
First Majestic Silver
AG
$9.28B
$81K ﹤0.01%
13,813
-268
-2% -$1.49K
WFT
1196
DELISTED
Weatherford International plc
WFT
$81K ﹤0.01%
144,646
-95,801
-40% -$125K
DSM
1197
BNY Mellon Strategic Municipal Bond Fund
DSM
$291M
$77K ﹤0.01%
11,000
VNRX icon
1198
VolitionRx Ltd
VNRX
$9.39M
$70K ﹤0.01%
1,933
+85
+5% +$4.04K
AKBA icon
1199
Akebia Therapeutics
AKBA
$233M
$68K ﹤0.01%
+12,225
New +$95.7K
ABDC
1200
DELISTED
Alcentra Capital Corp
ABDC
$66K ﹤0.01%
10,198

Similar funds

Oppenheimer & Co's Q4 2018 Portfolio in Review

As of Q4 2018, Oppenheimer & Co held 1,433 positions worth $3.2B, down 19% from $3.93B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer & Co withdrew a net $164M in Q4 2018, closing 196 positions and reducing 621 holdings. Its most notable exit was Etsy, an estimated $6.87M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 13% a quarter earlier, followed by Technology and Financials.

Against the trend, Oppenheimer & Co opened a new position in Linde worth $4.72M.

  • Oppenheimer & Co's largest Q4 2018 buy was Linde: 30,256 shares worth $4.72M.
  • Oppenheimer & Co added most to iShares 20+ Year Treasury Bond ETF in Q4 2018, an estimated $7.65M increase.
  • Oppenheimer & Co's biggest Q4 2018 reduction was Meta Platforms (Facebook), cutting an estimated $9.23M.
  • Oppenheimer & Co fully exited Etsy in Q4 2018, selling an estimated $6.87M.
  • Oppenheimer & Co's ten largest holdings make up 14% of its $3.2B portfolio in Q4 2018.
  • Oppenheimer & Co opened 85 new positions and closed 196 in Q4 2018.
  • Oppenheimer & Co's portfolio value fell 19% quarter-over-quarter to $3.2B.

Based on Oppenheimer & Co's 13F filing for Q4 2018, filed 29 Jan 2019.